From Our Partners
Tuesday, June 21, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

New Mutations Identified in Antibiotic-Resistant Bioterrorism Agent

by Global Biodefense Staff
November 3, 2016
Crystal Jaing LLNL

LLNL biologist and lead author Crystal Jaing loads a microarray chip into the holding cassette, which will go undergo fluorescent scanning of array signals. Photo by Randy Wong/LLNL.

Crystal Jaing LLNL - Francisella tularensis research
LLNL biologist Crystal Jaing with the structural model of topoisomerase enzyme FTL_1547. A mutation position is colored in red. Photo by Kate Hunts/LLNL.

In the first study to search the entire genome of Francisella tularensis bacteria for variations, researchers from Lawrence Livermore National Laboratory (LLNL) identified new mutations which confer resistance to ciprofloxacin (Cipro), one of the most common antibiotic treatments.

F. tularensis is a Category A Select Agent, a designation for organisms and toxins that pose the greatest risk to public health and safety, such as the microbes that cause anthrax and plague.

“This perspective allows you to see mutations that are new that we didn’t know about. If you don’t do this type of study, you’re going to miss other mechanisms that cause resistance in the bacteria. So by doing a genome-wide study, it gives you a much more complete picture about what’s going on,” said LLNL biologist and lead author Crystal Jaing.

The study found resistance-conferring mutations in a hypothetical protein, an asparagine synthase, and a sugar transamine/perosamine synthetase in addition to observing known variants.

Identifying functional mutations enable scientists to develop diagnostic tests to determine in a matter of hours if a bioweapon release is antibiotic resistant and if it might have been manipulated to be more pathogenic or for other reasons. Time is important especially in the case of F. tularensis because it can be spread as an aerosol, which makes it difficult to contain.

If doctors do not know the strain is resistant to Cipro, patients could be in a late stage of the infection before being provided with effective treatment.

Whether in response to bioterrorism or in everyday clinics, these tests could allow doctors to determine whether an infection is resistant to certain antibiotics before beginning treatment. Most often when a patient has a bacterial or viral infection, doctors must rely on past experience and trial and error. Cipro is frequently prescribed first, under the assumption that it normally is effective.

The LLNL team used DNA sequencing and DNA microarrays to inspect the entire genome. They also used protein modeling to predict structural and functional changes caused by the mutations and compare simulations to a database of known proteins. Structural changes can prevent the antibiotic drug from binding to the target protein, making it less or non-effective.

“Knowing if there’s any structural impact of that mutation will help us infer what the potential functional changes might be,” Jaing said.

The Department of Homeland Security Science and Technology Directorate funded the study. Eureka Genomics performed external sequencing and sequencing analysis.

Read the study at PLOS ONE: Identification of Genome-Wide Mutations in Ciprofloxacin-Resistant F. tularensis LVS Using Whole Genome Tiling Arrays and Next Generation Sequencing.

From Our Partners
Tags: F. tularensis

Related Posts

BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
Federal Select Agent Program Clarifies Requirements for Botulinum Neurotoxin Gene Constructs
Health Security

Federal Select Agent Program Clarifies Requirements for Botulinum Neurotoxin Gene Constructs

May 4, 2022
BugSeq Awarded BARDA DRIVe Funding to Develop Next-Gen Diagnostics for Any Respiratory RNA Virus
Health Security

BugSeq Awarded BARDA DRIVe Funding to Develop Next-Gen Diagnostics for Any Respiratory RNA Virus

May 3, 2022
Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents
CBRNE

Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents

April 11, 2022
Load More

Latest News

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Biodefense Headlines – 16 June 2022

Biodefense Headlines – 16 June 2022

June 16, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC